Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You too, I added as well. Felt good picking up more here. But I have been adding every week, so this week was no different.
I can't wait to see what February numbers are....we should see them next week I'm guessing.
You got that right. Patience is a virtue and a pathway to fortune here. If I didn't think this was ever going to NASDAQ I wouldn't still be here. I'm here and holding my shares tight. Love this company and management and will support them for years to come.
Suckers Sold Yesterday! I added! Felt Great!
RXMD!
Glad you are here too.
I'm with you my Friend
RXMD is Strong and Well!
Bottom Line is Dr. P told us from the beginning he was a trader
Glad he came here and made some money with some of his followeres
He was up front about it.
He also brought us exposure
He still states the fact that RXMD will go well above .25 in the near future.
So everyone relax
RXMD is Fine!
We all know that there is not one stock that trade green everyday.
I am happy people made some money
more people will come in and buy their shares pps goes up
they sell and they make money that is how it goes.
For us longs who have been here for over 3 years what is 12 months more
what is a fluctuation of .02 in the pathway to over $1?
remember that Ms. Mars and Armen always have a little extra for their shareholders
So take a break from the computer
get a stiff drink
Breath
and just
RELAX!
GLTA
Nice to have you here. Appreciate a good legal opinion.
Same group sold around 4c and expected it to go back to 3c and it never did and they ended up buying higher. It will happen again and they will end up buoying at higher PPS. Anyway this stock will move based on fundamentals and yesterday's action was clear and PPS jumped back up fast and all the shares went to strong hands.
Feb numbers, uptick interview and Wall Street conference details will be out next week, 2nd yr audit in 2-3 weeks, CBD product launch will happen anytime. This is the time to buy more folks.
My one post.
And Miss Mars will be releasing a audio on Monday , someone posted here , so should be more great news !
Holding my 2 milly still. There going to have to pry these bad boys out of my hands.
RXMD
Keep it going!
I am so patient. ;)
It's good to have the badguy here...he has been in RXMD for quite sometime. Myself, I've been here since 2015
red - I am an attorney. Your analysis is spot on.
Thats funny .
If it wasn't for the games people have been playing , we should be in the .30 range , we are still undervalued .
But great stock to be in , games and all
I can guarantee that the longs here did not sell a single share. We are holding for a much larger payday.
Retest .20 today??
With upcoming catalysts next week on Monday and possibly Feb numbers released by Thursday, we should be getting a nice little boost back up to the .20 level. Good numbers should take us right over the hump!
I have a prescription for the doctor and his buddies - buy RXMD to cure your money ailments!
Yesser $RXMD when it goes to NASDAQ in a few years at $4 well my first 1million stock
I will NEVER sell my free 250,000 shares OR $RXMD business would change 180° !
Blade
Hey bad g ,I was just wondering , are you still holding MCO* , I hope you got out .
And we do have our little pot of gold here .
Thank you, Ken! We'll ALL retire with RXMD!
NASDAQ caliber!
Hold your shares!
The Badguy
badguy baring soul to all! I think it's incredible you have the guts to show your actual holdings and account amount. You have incredible conviction in your pot stocks and of course RXMD. Sir, I believe you do have the potential to retire if you choose to simply buy CD's and bonds after this runup, just incredible what you can do with penny stocks.
Anyone selling RXMD when the MMs play their devious V cut games needs an education on MM tactics. MMs are trying to accumulate with YOUR GOLD!
Do NOT sell to them and do NOT panic!
RXMD is NASDAQ caliber!
Remember that fact!
Been with RXMD since 2012!
2016 photo below
Good investing!
The Badguy
Hey my friend I will keep a lot of shares from $RXMD but I sold yesterday half of my position at .2 that I bought at avg .019. I still have 250,000 free shares....but could't resist to take my shares of the table with some nice gains.
In the past I make a lot of mistakes not doing this....from mistakes I learn.
I hope half of my shares $RXMD going to NASDAQ some day...
Yes you’re absolutely right but the truth is some people lead and some people follow, its the herd mentality.
Im talking about the fact that what LOI means and its limitation. Besides that im NOT because out then want to talk it down for buyback reason, although sometimes i do take profit in my trading account, but most are locked and see how high it could fly after a few years......
Not unusual? It is a material event that requires disclosure.
You are wrong colorful. Parties can be held liable to elements of an LOI. An LOI has legal significance.
that is true. one location is a bottleneck in capacity, profit and cost of revenue. second location gives them twice the bandwidth and eventually lowers total cost of revenue. As more locations open later, everything improves exponentially.
Agreed they do it all the time.
Nobody made them do it. They could have done their own thing.
I agree with your logical thinking and reasonable assume that this time it must be a done deal, but the reality is that it is just a LOI and it cant be a contingent or a bonding agreement. This means that at any time all parties have the right not to accept the deal and not liable for compensation.
LOL, that was funny...I like better then your example
A letter of intent is a document outlining one or more agreements between two or more parties before the agreements are finalized. There is an agreement between the buyer and seller!!!!
https://en.wikipedia.org/wiki/Letter_of_intent
The deal is getting done, and the new location will increase RXMD's profit SIGNIFICANTLY due to the following:
- they've already been selling/delivering prescriptions in the Palm Beach area (where the store they are purchasing is located). Having a store there allows for reduced delivery costs while maintaining the customers using the store they're acquiring
- they have connections with doctors/hospitals in Palm Beach. With an actual store there, more people will want to utilize the convenient location. Overall increased sales, little to no delivery cost with these new customers.
- sharing of administrative costs which aren't specific to one store
The new location will have a significant, positive impact on the company's profitability.
Surely you saw. The group that exited today was no way in heck early holders, they were a group of flippers, dumped all their shares on the bid based on one guys wishes, which was based on absolutely nothing, they were just happy with their gains.
Great post. Once the acquisition goes thru.....and peeps analyze the revenues from the acquisition.... we launch to a dollar extremely fast.
This is a no-brainer.
Real company, outstanding revenues w/ an aggressive growth plan.
Load your boat.... add on any significant dips..... get paid....
GLTA
CC3
I mentioned last week and put forth several calculations to back a 35.5 cent a share valuation. My valuation was not based on having another location it was based on the current earnings. Some may be concerned that this acquisition may not go thru but my uttering was I hope they don’t anounce anything until they reach that .355 valuation. Friends, of course this acquisition would be awesome but we will get to .355 before it is finalized so all the energy spent on worry and discussion should rather return to the positiveness that was present before this LOI was even announced. Some people are losing sight of the fact that this company already has nice revenue, zero debt and a good management team. Please stay focused and keep your moral high, there is nothing to worry about.
Good grief! I was not implying there is a problem with the acquisition plan. I was countering one or so posts saying an LOI is not significant. I cited an example of breach of LOI used in a lawsuit. I also noted that an LOI is a material change that must be disclosed.
Is it a done deal? No. That's just an accurate statement. I have a slight obsession with accuracy.
Been watching RXMD these past 7 or so trading days... saying to myself ,Ok NO stock can be GREEN all day , every day...But RXMD WAS...Amazing....Saw this day coming....
If your UP $100k / over as it sounded here , on an OTC, your darn lucky. I knew these larger early holders , would cash in, sooner than later.....
Hope RXMD shakes this off, and starts heading NORTH .....this Chit happens all the time, every time...
Buy Low ,SELL HIGH.....
So we agree this will move on and RDMD is progressing!
Yes about like a weatherman, they are fairly accurate with the current weather beyond that is a guess.
A letter of intent is a material change in a company's profile. It needs to be disclosed for shareholders. That was sort of my point in saying it has legal significance.
Sure, I'm not concerned at all. That post was a point of clarification on the legal implications of an LOI. There was some back and forth on whether it was meaningless.
A question asked out of ignorance. Why disclose a LOI. Why not wait for a contract.
The LOI will almost certainly end with a done deal if you remember this:
The company has been open about having two near-deals fall through in 2017. Based on how they discussed them after they fell through, the deals were close to being done, but some things out of RX's power held up the deal. They didn't PR either of these because they could tell there was a chance the deals would fall through!
Since then, they've gotten asked on conference calls (after quarterly statements have been issued) about M&A opportunities. They've reiterated over and over that they're being picky and won't pursue something unless it's the right fit based on cost, profit, financing, and overall potential.
The fact that they've gone through with the Letter of Intent to Purchase, based on history, means that this purchase will come to fruition. I honestly don't think there's any reason for concern that this deal won't get done.
I was working & adding when I could!
Spot on assessment
All I've ever really taken away from Clay's charts - hey check it out the price is going up. If it keeps going up it will be higher. Watch out though, there are no guarantees. It might go down. I'm going to delete some unnecessary lines so you can see that the slope truly is going up. Go to my website and give me your money
Re LOI discussion. Letters of intent are not enforceable as contracts, but they are not without meaning in law. I don't have access to Florida laws, but this is from Westlaw's Texas database. Just a clip from the synopsis of a 2003 civil suit.
"lawsuit against defendants alleging, among other things, fraud, conversion, breach of fiduciary duty, civil conspiracy, breach of the nondisclosure agreement, breach of the letter of intent, and ... seeking damages and injunctive relief."
They are not necessarily a done deal, but they are matters of fact in civil actions.
Followers
|
746
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
194108
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |